Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 2/20 | 0.45 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.45 |
| ▸ | MAOB | P27338 | 8/20 | 0.44 |
| ▸ | MAOA | P21397 | 3/20 | 0.44 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.42 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6263243 | 0.75 | SCN3A (0.46) | LPAR1LPAR5MAOBMAOANR4A2 | |
| SCHEMBL3969640 | 0.73 | MAOB (0.59) | MAOBMAOANR4A2PARP10SCN9A | |
| SCHEMBL1070268 | 0.68 | MAOB (0.58) | MAOBMAOANR4A2PARP10SCN9A | |
| SCHEMBL3498062 | 0.66 | NR4A2 (0.72) | MAOBMAOANR4A2PARP10SCN9A | |
| SCHEMBL1069153 | 0.66 | SCN9A (0.57) | LPAR1LPAR5MAOBPARP10SCN9A | |
| SCHEMBL7396562 | 0.65 | MAOB (0.71) | MAOBMAOANR4A2PARP10SCN9A | |
| SCHEMBL9129876 | 0.65 | MAOB (0.71) | MAOBMAOANR4A2PARP10SCN9A | |
| SCHEMBL5536874 | 0.65 | MAOB (0.53) | MAOBMAOANR4A2PARP10SCN9A | |
| SCHEMBL3500758 | 0.65 | MAOB (0.63) | LPAR1LPAR5MAOBPARP10SCN9A | |
| SCHEMBL8935241 | 0.64 | MAOB (0.63) | MAOBMAOANR4A2PARP10SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005070405-A1 | ALPHA-AMINOAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF LOWER URINARY TRACT DISORDERS | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2005-08-04 | — | — | WO | claimed |